The REGN-COV2 Study

Ian L. -

The predominant value of these passive immunity treatments has been historically post and pre exposure prophylaxis as in tetanus hyperimmune globulin in patients with a Tetanus prone wound in whom regular tetanus boosters have lapsed . Before hepatitis A and B vaccines they were given as immunoglobulin for travel to hepatitis B and hepatitis A endemic areas . With a Rabies risk bite Hyperimmune Immunoglobulin is given as soon as possible after the bite with the active vaccine . -As regards the natural antibody response by people infected with Covid it was said the range of antibodies vary and some antibodies might be deleterious . If antibodies have been produced it cannot be that Early in the disease . -The mortality rate after admission to hospital is high between 9-15 % in a JAMA report 22 December 2020 by Asch D A et al -you have to give the patients the option especially after the n 1 of President Trump .

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
Mobile Video (180p) 66.5 MB - MP4Small Video (400p) 66.7 MB - MP4Standard Video (720p) 339 MB - MP4